Common T-Cell-Receptor Motifs and Features in Patients with Cytomegalovirus (CMV)-Seronegative End-Stage Renal Disease Receiving a Peptide Vaccination against CMV

After solid-organ transplantation, reactivation of the cytomegalovirus (CMV) is often observed in seronegative patients and associated with a high risk of disease and mortality. CMV-specific T cells can prevent CMV reactivation. In a phase 1 trial, CMV-seronegative patients with end-stage renal dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Bunse, Lukas, Sommerer, Claudia, Tan, Chin Leng, Korell, Felix, Schmitt, Anita, Hückelhoven-Krauss, Angela, Neuber, Brigitte, Mertens, Thomas, Platten, Michael, Green, Edward W., Zeier, Martin, Schmitt, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835207/
https://www.ncbi.nlm.nih.gov/pubmed/35162953
http://dx.doi.org/10.3390/ijms23031029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835207/
https://www.ncbi.nlm.nih.gov/pubmed/35162953
http://dx.doi.org/10.3390/ijms23031029

Ejemplares similares